p53 modulates the effect of ribosomal protein S6 kinase1 (S6K1) on cisplatin toxicity in chronic myeloid leukemia cells

Medicine & Life Sciences

• Ribosomal Protein S6 100%
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive 70%
• Myeloid Cells 68%
• S 6 56%
• Blast Crisis 41%
• Phosphorylation 16%
• 3-Phosphoinositide-Dependent Protein Kinases 10%
• Oncogene Proteins 6%
• Phosphatidylinositols 6%
• Protein Kinases 5%
• DNA Damage 5%
• Lung Neoplasms 4%
• Cell Death 4%
• Drug Therapy 3%
• DNA 3%
• Pharmaceutical Preparations 2%